Meta-analysis was used to calculate maternal serum marker distribution parameters for Down syndrome risk estimation in the first trimester. Data from 44 series were combined: relating to pregnancy associated plasma protein (PAPP)-A in 18, free human chorionic gonadotrophin (hCG) in 17, -fetoprotein
First-trimester biochemical markers for Down syndrome
✍ Scribed by Elena Casals; Carlos Aibar; Josep Maria Martínez; Antoni Borrell; Anna Soler; Julia Ojuel; Antonio Manuel Ballesta; Albert Fortuny
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 154 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0197-3851
No coin nor oath required. For personal study only.
✦ Synopsis
The value of maternal serum pregnancy-associated protein A (PAPP-A), free and total human chorionic gonadotrophin (f hCG, hCG) and -fetoprotein (AFP) in screening for Down syndrome (DS) in early pregnancy has been assessed. To evaluate the different biochemical markers, 32 DS pregnancies and 267 controls were used for AFP, hCG and PAPP-A. A subgroup of those (17 DS and 136 controls) were used to evaluate f hCG. All analytes were determined in fresh serum samples. Our results give support to the feasibility of maternal serum levels of PAPP-A as the best biochemical marker for DS in the first trimester, and either hCG or f hCG as the second marker. No differences were found between hCG and f hCG distribution levels as expressed as MoMs in normal and DS pregnancies in this study.
📜 SIMILAR VOLUMES
Ultrasound dating in first-trimester biochemical screening for Down syndrome We have read with interest the article by Macintosh ef al. (1995) which describes the effects of ultrasound estimation of gestational age on the performance of first-trimester biochemical screening for fetal aneuploidy. I
Data on pregnancies with and without Down's syndrome between 10 and 14 weeks of pregnancy were used to determine the performance of combined ultrasound and biochemical markers in prenatal screening for Down's syndrome. We used three datasets: one published by on nuchal translucency measurement in 8
The potential of the maternal serum concentration of schwangerschaftsprotein 1 (MSSP1) as a marker for Down syndrome (DS) pregnancies was evaluated in the fifth to the 20th gestational week using 156 DS pregnancies and 546 unaffected control pregnancies. In DS pregnancies, the median of the multiple